Literature DB >> 15811116

Chondrodermatitis nodularis helicis as a marker of internal disease [corrected] associated with microvascular injury.

Cynthia M Magro1, Gwyn E Frambach, A Neil Crowson.   

Abstract

Chondrodermatitis nodularis helicis (CNH) is held to be an idiopathic degenerative process involving the upper dermis of the auricular rim. Chondrodermatitis typically occurs in elderly men where associations with underlying trauma and sun exposure have been postulated as potential inciting triggers. Its association as a marker of systemic disease is not well established. We describe 24 patients with CNH, in whom there were also significant underlying diseases largely associated with vascular injury including those of immune-based etiology and/or conditions which have been previously linked with granuloma annulare, another necrobiotic process of collagen. These patients with concomitant systemic disease were characteristically younger compared to the classic demographics described for CNH. In some cases, chondrodermatitis may represent an ischemic necrobiotic disorder of collagen, potentially defining an important sign of underlying systemic disease in younger patients.

Entities:  

Mesh:

Year:  2005        PMID: 15811116     DOI: 10.1111/j.0303-6987.2005.00317.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

Review 1.  Therapeutic Options of Chondrodermatitis Nodularis Helicis.

Authors:  Lea Juul Nielsen; Caroline Holkmann Olsen; Jørgen Lock-Andersen
Journal:  Plast Surg Int       Date:  2016-01-27

2.  The Direct Use of Mobile Phone and the Occurrence of Chondrodermatitis Nodularis in the Antihelix: An Exemplificative Case.

Authors:  Federica Di Berardino; Diego Zanetti
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec

3.  Pediatric chondrodermatitis nodularis chronica helicis.

Authors:  Li-Wen Zhang; Lin Li; Cong-Hui Li; Wen-Ju Wang
Journal:  An Bras Dermatol       Date:  2020-03-19       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.